Soleno shares opened 33% higher, marking their biggest intraday gain since March 2025. Neurocrine Biosciences announced on Monday that it will acquire Soleno Therapeutics for $2.9 billion in cash.

2026-04-06

Soleno shares opened 33% higher, marking their biggest intraday gain since March 2025. Neurocrine Biosciences announced on Monday that it will acquire Soleno Therapeutics for $2.9 billion in cash.